564 related articles for article (PubMed ID: 26554150)
1. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Glasgow MD; Chougule MB
J Biomed Nanotechnol; 2015 Nov; 11(11):1859-98. PubMed ID: 26554150
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in nanotechnology for cancer therapy.
Tang MF; Lei L; Guo SR; Huang WL
Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
[TBL] [Abstract][Full Text] [Related]
3. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
[TBL] [Abstract][Full Text] [Related]
6. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer.
Yang J; Lee CH; Ko HJ; Suh JS; Yoon HG; Lee K; Huh YM; Haam S
Angew Chem Int Ed Engl; 2007; 46(46):8836-9. PubMed ID: 17943947
[No Abstract] [Full Text] [Related]
8. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
9. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
10. Polymer decorated gold nanoparticles in nanomedicine conjugates.
Capek I
Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
[TBL] [Abstract][Full Text] [Related]
11. Liposome-based drug co-delivery systems in cancer cells.
Zununi Vahed S; Salehi R; Davaran S; Sharifi S
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1327-1341. PubMed ID: 27987688
[TBL] [Abstract][Full Text] [Related]
12. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-based nanoparticles for cancer therapy.
Baker JR
Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
16. Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.
Siegler EL; Kim YJ; Chen X; Siriwon N; Mac J; Rohrs JA; Bryson PD; Wang P
Mol Ther; 2017 Dec; 25(12):2607-2619. PubMed ID: 28919377
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
18. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines in Diagnosis and Treatment of Cancer: An Update.
Haider N; Fatima S; Taha M; Rizwanullah M; Firdous J; Ahmad R; Mazhar F; Khan MA
Curr Pharm Des; 2020; 26(11):1216-1231. PubMed ID: 32188379
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
